Collegium Pharmaceutical, Inc (COLL) stock
COLLNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 10/3045% below fair value
$24.81+0.34 (+1.39%)
Close on Nov 11, 2026Market cap $807.71MP/E 24.8Yield –
Collegium Pharmaceutical operating margin
Operating margin is operating income as a percentage of revenue.
Collegium Pharmaceutical's operating margin for the twelve months ending Sep 30, 2026 was 15.2%. For fiscal 2025 it was 23.0%, against 26.9% the year before. The highest annual figure on record is 29.5% in fiscal 2023.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 23.0% | −3.9 |
| FY2024 | Dec 31, 2024 | 26.9% | −2.6 |
| FY2023 | Dec 31, 2023 | 29.5% | +22.3 |
| FY2022 | Dec 31, 2022 | 7.2% | +0.8 |
| FY2021 | Dec 31, 2021 | 6.4% | −11.8 |
| FY2020 | Dec 31, 2020 | 18.1% | +26.1 |
| FY2019 | Dec 31, 2019 | -8.0% | −0.6 |
| FY2018 | Dec 31, 2018 | -7.4% | +257.6 |
| FY2017 | Dec 31, 2017 | -264.9% | +5233.7 |
| FY2016 | Dec 31, 2016 | -5498.7% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 13.3% | −16.4 |
| Q2 FY2026 | Jun 30, 2026 | 1.9% | −16.8 |
| Q1 FY2026 | Mar 31, 2026 | 16.0% | +3.8 |
| Q4 FY2025 | Dec 31, 2025 | 29.6% | +8.6 |
| Q3 FY2025 | Sep 30, 2025 | 29.7% | +7.8 |
| Q2 FY2025 | Jun 30, 2025 | 18.7% | −14.0 |
| Q1 FY2025 | Mar 31, 2025 | 12.2% | −21.9 |
| Q4 FY2024 | Dec 31, 2024 | 20.9% | −20.2 |
| Q3 FY2024 | Sep 30, 2024 | 21.9% | −11.1 |
| Q2 FY2024 | Jun 30, 2024 | 32.7% | +6.4 |
| Q1 FY2024 | Mar 31, 2024 | 34.1% | +17.1 |
| Q4 FY2023 | Dec 31, 2023 | 41.2% | +32.1 |
| Q3 FY2023 | Sep 30, 2023 | 32.9% | +16.8 |
| Q2 FY2023 | Jun 30, 2023 | 26.3% | +17.3 |
| Q1 FY2023 | Mar 31, 2023 | 17.0% | +29.0 |
| Q4 FY2022 | Dec 31, 2022 | 9.1% | +133.8 |
| Q3 FY2022 | Sep 30, 2022 | 16.1% | −1.8 |
| Q2 FY2022 | Jun 30, 2022 | 9.0% | −10.8 |
| Q1 FY2022 | Mar 31, 2022 | -12.0% | −36.1 |
| Q4 FY2021 | Dec 31, 2021 | -124.7% | −144.4 |
| Q3 FY2021 | Sep 30, 2021 | 17.9% | −6.8 |
| Q2 FY2021 | Jun 30, 2021 | 19.8% | −1.4 |
| Q1 FY2021 | Mar 31, 2021 | 24.2% | +17.5 |
| Q4 FY2020 | Dec 31, 2020 | 19.7% | +22.9 |
| Q3 FY2020 | Sep 30, 2020 | 24.8% | +33.5 |
| Q2 FY2020 | Jun 30, 2020 | 21.2% | +27.9 |
| Q1 FY2020 | Mar 31, 2020 | 6.6% | +20.0 |
| Q4 FY2019 | Dec 31, 2019 | -3.2% | −18.2 |
| Q3 FY2019 | Sep 30, 2019 | -8.7% | +7.2 |
| Q2 FY2019 | Jun 30, 2019 | -6.7% | +3.3 |
| Q1 FY2019 | Mar 31, 2019 | -13.4% | +7.3 |
| Q4 FY2018 | Dec 31, 2018 | 15.0% | +177.9 |
| Q3 FY2018 | Sep 30, 2018 | -15.9% | +96.4 |
| Q2 FY2018 | Jun 30, 2018 | -10.0% | +587.2 |
| Q1 FY2018 | Mar 31, 2018 | -20.7% | +1046.3 |
| Q4 FY2017 | Dec 31, 2017 | -162.9% | +1953.7 |
| Q3 FY2017 | Sep 30, 2017 | -112.4% | – |
| Q2 FY2017 | Jun 30, 2017 | -597.1% | – |
| Q1 FY2017 | Mar 31, 2017 | -1067.0% | – |
| Q4 FY2016 | Dec 31, 2016 | -2116.6% | – |
See a number that looks wrong?